Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
|Videos|May 18, 2021
Maintaining health and wellbeing in residency and beyond
Author(s)Lindsey Carr, Editor, Laura E. Riley, MD
Laura E. Riley, MD gives advice to residents, and practitioners just beginning their careers, on maintaining a healthy lifestyle while balancing the demands of the workplace. She is joined by Contemporary OB/GYN®’s Associate Editor, Lindsey Carr.
Advertisement
Riley is Chair of the Department of Obstetrics and Gynecology at Weill Cornell Medicine and Obstetrician and Gynecologist-in-Chief at New York-Presbyterian/Weill Cornell Medical Center in New York, New York. Riley is also one of the newest members of
Advertisement
Related to this article
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Brain fog at menopause: Separating normal change from dementia
3
Neurokinin receptor antagonists improve menopausal sleep disturbance
4
Stephanie Faubion, MD, on the first menopause therapy discussion
5